Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Lenalidomide worsens survival, adverse events in prostate cancer

A combination of lenalidomide plus docetaxel and prednisone treatment in patients with chemotherapy-naive prostate cancer leads to worse overall survival rates and increased toxicity compared with placebo, show study results.

12 Oct 2012

AACR conference to focus on scientific and lifestyle strategies for cancer prevention

The American Association for Cancer Research will host the 11th Annual AACR International Conference on Frontiers in Cancer Prevention Research at the Hilton Anaheim from Oct. 16-19, 2012.

12 Oct 2012

Recommendations in pediatric palliative care

The future of pediatric and perinatal palliative care should include accepting parents’ need for proximity to the child, combining the strategies of palliative and intensive care physicians, improving healthcare providers’ listening skills, and involving multiple disciplines, recommend researchers.

11 Oct 2012

Theragenics enters second amended and restated credit agreement with Wells Fargo

Theragenics Corporation, a medical device company serving the surgical products and prostate cancer treatment markets, today announced that it has entered into a Second Amended and Restated Credit Agreement with Wells Fargo Bank, National Association.

11 Oct 2012

MD Anderson, Methodist create new 3D model for lung cancer research

A new technique that allows scientists to grow lung cancer cells in three dimensions could accelerate discoveries for a type of cancer that has benefited little from scientific research over the last several decades.

11 Oct 2012

Addiction and mental health burden higher than all cancers in Ontario

Mental illnesses and addictions take more of a toll on the health of Ontarians than cancer or infectious diseases, according to a new report by the Institute for Clinical Evaluative Sciences and Public Health Ontario - yet this burden could be reduced with treatment, say scientists from Canada's Centre for Addiction and Mental Health.

11 Oct 2012

Six-gene signature can predict survival in men with aggressive prostate cancer

Researchers from Mount Sinai School of Medicine have identified a six-gene signature that can be used in a test to predict survival in men with aggressive prostate cancer, according to new research published in the October issue of The Lancet Oncology.

11 Oct 2012

UCSF project to explore mystery behind advanced prostate cancer

Many men survive prostate cancer, but thousands of others -- whose cancer spreads -- inevitably develop resistance to even the most promising treatments, leaving them with few medical options and a dwindling span of life.

10 Oct 2012

Spanish and British scientists design new blood test to identify aggressive prostate cancer

Scientists from the Spanish National Cancer Research Centre (CNIO) in Madrid, along with British colleagues from the Institute for Cancer Research (ICR) and the Royal Marsden NHS Foundation Trust, have developed a test that studies genetic patterns in blood cells to detect advanced-stage prostate cancer.

10 Oct 2012

PARP-1 plays a major role in controlling AR function in prostate cancer patients

A newly discovered function of PARP-1 could be the key to more effective therapeutics to treat advanced prostate cancer patients, a recent preclinical study published in Cancer Discovery by Jefferson's Kimmel Cancer Center researchers suggests.

10 Oct 2012

Early communication strategies improve end of liver transplant patients’ lives

A multidisciplinary communication intervention involving physicians and family members of liver transplant patients treated in surgical intensive care units can improve end-of-life care, show study results.

9 Oct 2012

New blood test can read genetic changes in prostate cancer

Scientists have designed a blood test that reads genetic changes like a barcode - and can pick out aggressive prostate cancers by their particular pattern of gene activity.

9 Oct 2012

CINJ physicians named among 2012 list of U.S. News Top Doctors

Several physicians at The Cancer Institute of New Jersey (CINJ), who are faculty members at the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, have been named as a 'Top Doctor' by U.S. News & World Report.

5 Oct 2012

Palliative focus needed in skilled nursing facilities

US data suggest that use of Medicare benefit for skilled nursing facilities is high during the last 6 months of life, highlighting a need to incorporate quality palliative care services in nursing homes, suggest researchers.

4 Oct 2012

Routine screening influences outcomes in prostate cancer after surgery

Men who undergo radical prostatectomy for a tumor that was detected by screening show better long-term outcomes than their peers who undergo the surgery after opportunistic diagnosis, study results show.

3 Oct 2012

ASTRO selects Boston-area resident as 2012 Survivor Circle Award winner

The American Society for Radiation Oncology (ASTRO) has selected Boston-area resident and prostate cancer survivor Emanuel "Manny" Hamelburg as its 2012 Survivor Circle Award winner.

3 Oct 2012

Adjuvants underused initially, follow up needed for cancer patients in pain

Italian study results indicate that physicians underuse adjuvant therapies for treatment of pain in cancer in the first instance, and that close follow up of oncology patients is needed to improve the efficacy of analgesic therapy in this setting.

2 Oct 2012

Genetic profile predicts postradiation erectile dysfunction

Scientists have identified a group of genetic markers that can predict the risk for erectile dysfunction after radiotherapy for prostate cancer.

1 Oct 2012

Active Biotech, Ipsen announce new data on biomarkers from tasquinimod Phase II study in CRPC

Active Biotech and Ipsen have presented a new set of data on biomarkers from the previously concluded tasquinimod Phase II study in chemotherapy-naïve metastatic castrate resistant prostate cancer (CRPC) at the scientific congress ESMO (European Society for Medical Oncology) held in Vienna September 28-October 2.

1 Oct 2012

Exelixis announces interim data from cabozantinib phase 2 trial on metastatic CRPC

Exelixis, Inc. today announced interim data from 51 patients with metastatic castration-resistant prostate cancer (CRPC) and bone metastases receiving a 40 mg daily dose of cabozantinib in an ongoing non-randomized expansion (NRE) cohort of a phase 2 randomized discontinuation trial.

1 Oct 2012

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Lenalidomide worsens survival, adverse events in prostate cancer

AACR conference to focus on scientific and lifestyle strategies for cancer prevention

Recommendations in pediatric palliative care

Theragenics enters second amended and restated credit agreement with Wells Fargo

MD Anderson, Methodist create new 3D model for lung cancer research

Addiction and mental health burden higher than all cancers in Ontario

Six-gene signature can predict survival in men with aggressive prostate cancer

UCSF project to explore mystery behind advanced prostate cancer

Spanish and British scientists design new blood test to identify aggressive prostate cancer

PARP-1 plays a major role in controlling AR function in prostate cancer patients

Early communication strategies improve end of liver transplant patients’ lives

New blood test can read genetic changes in prostate cancer

CINJ physicians named among 2012 list of U.S. News Top Doctors

Palliative focus needed in skilled nursing facilities

Routine screening influences outcomes in prostate cancer after surgery

ASTRO selects Boston-area resident as 2012 Survivor Circle Award winner

Adjuvants underused initially, follow up needed for cancer patients in pain

Genetic profile predicts postradiation erectile dysfunction

Active Biotech, Ipsen announce new data on biomarkers from tasquinimod Phase II study in CRPC

Exelixis announces interim data from cabozantinib phase 2 trial on metastatic CRPC

What to know about prostate cancer eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in